Enforcement record

Business Suspension Order disclosure naming 株式会社エール薬品

株式会社エール薬品 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareGovernment disclosure13 April 2017

Action type

Business Suspension Order

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

13 April 2017

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Free report

Save the disclosure record naming 株式会社エール薬品

Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Preserved evidence by Kiroku

Review the preserved source for 株式会社エール薬品

Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.

Open preserved source and evidence pack
For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?company=%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E3%82%A8%E3%83%BC%E3%83%AB%E8%96%AC%E5%93%81&limit=10

Action summary

Company
株式会社エール薬品Japanese only
Original: 株式会社エール薬品
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
医薬品医療機器等法
Action type
Business Suspension Order
業務停止命令
Action date
13 April 2017
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省
Industry context
医薬品卸売業

Violation

Machine-translated summary — verify against original

Sale of counterfeit products (including distribution).

Show original Japanese text

偽造品の販売(授与を含む。)

Compliance context

High

A formal order requiring suspension of business activities for the covered scope or period.

Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.

Escalate for legal or third-party risk review before onboarding or continuing a material relationship.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack
Extracted at
2026-04-24T23:35:29.549+00:00
Evidence checked
2026-04-24T23:35:29.549+00:00
Archive captured
2026-07-12T06:25:11.465616+00:00
Show audit JSON
{
  "record": {
    "id": "c520dcc4-f8de-4d4f-a3b3-304f7d29ff54",
    "url": "https://regbase.jp/en/enforcement/other-eruyao-pin-20170413",
    "company_name_original": "株式会社エール薬品",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "医薬品医療機器等法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "業務停止命令",
      "en": "Business Suspension Order"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 85,
    "method": "nta_strict_name_nationally_unique",
    "method_label": "nta_strict_name_nationally_unique",
    "notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (株式会社エール薬品). No Corporate Number was present in the disclosure, so this remains a likely match."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "High",
    "actionMeaning": "A formal order requiring suspension of business activities for the covered scope or period.",
    "practicalNote": "Escalate for legal or third-party risk review before onboarding or continuing a material relationship.",
    "lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-eruyao-pin-20170413",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000161594.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/ce12b1f637hemgz9",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000161594.html",
    "archiveCapturedAt": "2026-07-12T06:25:11.465616+00:00",
    "extractedAt": "2026-04-24T23:35:29.549+00:00",
    "translatedAt": "2026-05-01T06:50:40.38+00:00",
    "evidenceCheckedAt": "2026-04-24T23:35:29.549+00:00",
    "generatedAt": "2026-07-26T12:20:34.401Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.